The largest database of trusted experimental protocols

37 protocols using muller hinton agar

1

Antagonism Assay of Lactobacillus fermentum

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antagonism tests were performed using the overlay method [37 (link)]. L. fermentum ATCC 23271 grown on MRS agar was standardized at OD600nm = 0.1, in MRS broth, and then 5 μL of the inoculum was spotted (about 0.9 cm) on MRS agar (Difco Laboratories, Detroit, MI, USA) and incubated for 48 h under the same conditions. After that period, a 2 mm layer of Muller–Hinton agar (Difco Laboratories) was added onto MRS agar, and the standard pathogen inoculum (1 × 108 CFU/mL) was seeded. Petri dishes were incubated at 37 °C for 24 h under aerobic conditions, and subsequent zones of inhibition were measured.
+ Open protocol
+ Expand
2

Antimicrobial Evaluation of Plant Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pure colonies of each microorganism were suspended in sterile saline until a turbidity match McFarland tube number 0.5 (1.5 × 108 CFU/ ml). A loopful from each adjusted organisms were swabbed onto Muller Hinton agar (Difco Laboratories). Sterile paper discs (6 mm in diameter) were impregnated with 100 μl of each 10%, 25%, 50%, 75% and 100% diluted extracts then dried at 100 °C for two hours in hot air oven and were dispensed onto the surface of the inoculated agar plate. The plates were then incubated according to growth requirement of each organism. Each sample was tested in triplicates and antibacterial activity was evaluated by measuring and recorded the zones of inhibition in mm (including the 6 mm disk). A parallel analysis study with commercial antimicrobial agents included Amoxicillin-Clavulinic (10 μg), Ampicillin (10 μg), Vancomycin (30 μg), Lincomycin (30 μg), Gentamicin (10 μg), Streptomycin (10 μg) and Tetracycline (30 μg) was conducted in order to compare their antimicrobial potency with the plant extracts.
+ Open protocol
+ Expand
3

Antibiotic Susceptibility Testing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The susceptibility testing of studied isolates was performed by disc diffusion method (modified Kirby-Bauer method) using Muller-Hinton agar (Becton Dickinson, MA, USA) and interpreted according to the Clinical Laboratory Standard Institute (CLSI) guidelines [11 ]. The antibiotic disks used imipenem (IPM, 10 μg), amikacin (AK, 30 μg), ciprofloxacin (CIP, 5 μg), piperacillin (PRL, 100 μg), cefoperazone/sulbactam (CES, 10 + 5 μg), cefoxitin (FOX, 30 μg), and cefotaxime (CTX, 30 μg) which were placed 15 mm away from the central disc and the plates were incubated for about 18–24 hrs at 37°C.
+ Open protocol
+ Expand
4

Genotypic and Phenotypic Analysis of Vibrio cholerae

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seventy-six V.cholerae isolates were identified from different geographic locations during 2007-2010 representing multiple cholera outbreaks. Of the 76 isolates, 56 were from multiple outbreaks at distinct geographic locations during 2009 and the other 20 isolates were from 2007, 2008 and 2010. The V. cholerae isolates were preserved at -80°C and revived by inoculation into alkaline peptone water at 37°C for 6 hrs and then subcultured on thiosulfate citrate bile salts sucrose agar (TCBS, EiKen Tokyo, Japan) and incubated at 37°C for 18-24 hrs. Suspected V. cholerae colonies were subcultured onto Muller-Hinton agar (Becton, Dickson (BD) and company, Sparks, MD, USA) plates and incubated at 37°C for 18-24 hrs [7 ]. All the isolates were confirmed by biochemical reactions based on sugar fermentation, oxidase test and serology using polyvalent O1, and monovalent Ogawa, and Inaba antisera. Of the 76 V. cholerae isolates, 44 representative ones were randomly selected for antimicrobial susceptibility testing and PFGE using NotI, based on their period of isolation and the area of the outbreak (3 isolates from 2007, 4 from 2008, 31 from 2009 and 6 from 2010). For ribotyping by BglI digestion, 26 strains were selected to represent cholera cases from various affected areas at different periods.
+ Open protocol
+ Expand
5

Antibiotic Susceptibility of H. pylori

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the MICs of CLR, CLSI agar dilution method was used [43 ]. Briefly, two-fold dilutions of CLR were prepared in Muller-Hinton agar (Becton Dickinson, MD) with 5% sheep blood. Following the preparation of H. pylori suspension in physiological saline adjusted to a 2.0 McFarland standard, a 1 to 3 μl inoculum was spotted on agar plate. Following incubation at 37°C for 72 h under microaerophilic atomosphere, the MICs of CLR were established as the drug concentration showing no growth.
+ Open protocol
+ Expand
6

In Vitro Antibacterial Activity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro antibacterial activities were determined using the broth microdilution method [22 (link)]. Assays were performed as described in Clinical and Laboratory Standards Institute protocols in triplicate using cation-adjusted Muller–Hinton broth (Becton Dickinson and Company, Franklin Lakes, NJ, USA) in 96-well plates with a total assay volume of 100 µL. Two-fold serial dilutions of test compounds were prepared over the concentration range of 1–64 µg/mL. The bacterial concentration was adjusted to OD600 = 0.06. MW2 was incubated with the test compounds at 37 °C for 18 h, OD600 was measured and the lowest concentration of each compound that visually inhibited bacterial growth was reported as the minimal inhibitory concentration (MIC) [23 (link)]. A 10 µL aliquot from each well in the MIC assays was plated onto Muller–Hinton agar (Becton Dickinson and Company, Franklin Lakes, NJ, USA) and incubated overnight at 37 °C. The lowest concentration of compound for which no growth was observed on agar plates was reported as the minimal bactericidal concentration (MBC).
+ Open protocol
+ Expand
7

Cultivation of Bioluminescent K. pneumoniae

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bioluminescent strain K. pneumoniae Xen 39 (PerkinElmer, Waltham, MA, USA) was constructed by introduction of a copy of the luxCDABE operon on the chromosome through conjugation and transposition of a special plasmid. K. pneumoniae was cultured in Muller–Hinton agar (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). The freshly plated K. pneumoniae was cultured in Mueller–Hinton broth to logarithmic phase at 37 °C for 6 h. Finally, K. pneumoniae was suspended at 1.0 McFarland by Densimat photometer (BioMérieux, Marcy l’Etoile, France).
+ Open protocol
+ Expand
8

Antibiotic Susceptibility Testing of Bacterial Isolates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The susceptibility profiles of bacterial isolates were determined by antibiogram using the Kirby-Bauer method on Muller Hinton agar (Becton Dickinson, New Jersey, USA), following the standard procedures of the Clinical and Laboratory Standards Institute.20 For this purpose, the following antibiotics were used: amoxicillin/clavulanic acid (10 μg/4 μg), ampicillin-sulbactam (10 μg/10 μg), ceftazidime (30 μg), cefotaxime (30 μg), cefepime (30 μg), cefoxitin (30 μg), piperacillin-tazobactam (100/10 μg), aztreonam (30 μg), imipenem (10 μg), meropenem (10 μg), gentamicin (10 μg), amikacin (30 μg), ciprofloxacin (5 μg), sulphamethoxazole/trimethoprim (25 μg), tetracycline (30 μg), ertapenem (10 μg), cefuroxime (30 μg), chloramphenicol (30 μg), and doripenem (10 μg) (OXOID, Hampshire, United Kingdom). Minimum inhibitory concentration (MIC) against selected β-lactams of ceftazidime, cefotaxime, aztreonam, cefepime, imipenem, meropenem, and ertapenem were performed in micro-dilution broth in concentrations of 0.03–32 μg/mL with and without β-lactamase inhibitors such clavulanic acid (4 μg/mL) and phenyl boronic acid (400 μg/mL) (Sigma Aldrich, Stenheim, Germany). E. coli ATCC 25922 was used as the control organism for antibiotic susceptibility. Procedures and interpretations of antibiotic susceptibility results were carried out according to the CLSI 2016 guidelines.20 , 21 (link)
+ Open protocol
+ Expand
9

Antimicrobial Susceptibility Assay of Bacteria

Check if the same lab product or an alternative is used in the 5 most similar protocols
The clinical isolate of strains 119 (S. aureus MSSA) and 3 (E. coli) was used for antimicrobial assay. A suspension of S. aureus or E. coli was prepared by the colony suspension method: three to five colonies from a nonselective nutrient agar medium incubated at 37 °C for 18 h were taken by a loop and moved to a sterile 0.9% sodium chloride solution. The suspension was adjusted to produce turbidity equivalent to 0.5 McFarland standard, corresponding to approximately 1.5 × 108 CFU × mL–1 of bacteria. Then, the obtained suspension was diluted to produce bacterial density equal to 1.5 × 106 CFU × mL–1. The tested sample in calculated concentration was suspended in 1.0 mL of Mueller–Hinton Broth (Becton Dickinson, Franklin Lakes, NJ, USA). The resulting concentration of the sample in the wells varied from 63 to 1000 μg/mL. After 100 μL of the suspension was added to the microplate wells and then the wells were inoculated with 100 μL of the bacterial suspension. Microplates were incubated at 37 °C for 18 h. After incubation, the material from each well was seeded on Muller Hinton Agar (Becton Dickinson, Franklin Lakes, NJ, USA) for the quantitative counting of surviving cells using 10-fold dilution series. Petri dishes were incubated at 37 °C for 18 h After incubation, the grown colonies were counted, and the number of CFUs was calculated.
+ Open protocol
+ Expand
10

Conjugation Assay for mcr-10.1 Transfer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conjugation experiments were performed with strain SL12517 used as a donor and rifampin-resistant Escherichia coli EC600 as a recipient (38 (link), 39 (link)). Donor and recipient strains (3 mL each) were cultured overnight at 37°C and mixed together. The mixed cells were harvested by centrifugation for 3 min at 1,200 × g, washed with 3 mL of Luria-Bertani (LB) broth and resuspended in 150 μL of LB broth. The mixture was spotted on a 1-cm2 hydrophilic nylon membrane filter with a 0.45-μm pore size (Millipore), which was placed on an LB agar plate and then incubated for mating at 37°C for 6 h. The cells were recovered from the filter membrane and spotted on Muller-Hinton (MH) agar (BD Biosciences) plates containing 1,500 μg/mL rifampin and 4 μg/mL colistin for selecting an mcr-10.1-carrying transconjugant.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!